Primary Recommendation

Al Noor Hospitals - Hospitals group forecast to grow eps 88% over next three years

October 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in Al Noor Hospitals, the largest integrated private healthcare provider in the United Arab Emirates (UAE), have already enjoyed a blistering run following their introduction to the Full List at 575p but we believe the best is yet to come. The company, which owns three hospitals and ten medical centres in Abu Dhabi, has seen demand soar on the back of an ageing population and poor lifestyle choices, which have led to increased incidences of diabetes, obesity, cancer and cardiovascular diseases. You might think that a country supported by the wealth of its huge oil & gas reserves wouldn't need private sector help to look after its people, but a surge in the number of foreigners coming here for work has caused the authorities to ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Restaurant Group - Record pipeline of new sites points to acceleration in growth rate

N Brown - Shares strong ahead of results on 9th October

Al Noor Hospitals - VPSâ€ˆHealthcare and NMC could yet gatecrash agreed Mediclinic offer (December 2015)

Al Noor Hospitals - In merger talks (November 2015)

Al Noor Hospitals - Shares hit by director sale (June 2015)

Al Noor Hospitals - Shares hit new high (October 2014)

Al Noor Hospitals (June 2014)

Al Noor Hospitals (April 2014)

Al Noor Hospitals - Third acquisition post float (February 2014)

Al Noor Hospitals - Makes its first two acquisitions (December 2013)

AL Noor Hospitals - Exciting new issue in fast growing Middle East private health care market (August 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X